Perioperative Management for Port Catheter Procedures in Pediatric Patients with Severe Hemophilia and Inhibitors
Hämostaseologie · 01.04.2026 · 46 (02) · 136-140
DOI: 10.1055/a-2337-3687 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hämostaseologie, erschienen am 01.04.2026. Verfasst von Anna Woestemeier und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department for General, Visceral, Thoracic and Vascular Surgery, University Hospital of Bonn, Bonn, Germany. Hauptthemen laut MEDLINE: Hemophilia A, Perioperative Care. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The objective of this systematic study was to assess the perioperative management and outcome of surgery in pediatric patients with hemophilia A/B and inhibitors compared to nonhemophilic pediatric patients.
Methods
The surgical outcome of 69 port catheter operations in patients with hemophilia who developed inhibitory antibodies against the administered factor was compared to 51 procedures in the control group. In the patients with hemophilia and inhibitors, a standardized protocol for recombinant activated factor VII was used to prevent perioperative bleeding.
Results
Hemophilic pediatric patients with inhibitors showed no significant differences in perioperative management (blood transfusion: p = 0.067, duration of surgery: p = 0.69; p = 0.824) in comparison to patients without hemophilia. The length of hospital stay was significantly longer in pediatric patients with hemophilia and inhibitors (20 days vs. 4 days for insertion; 12 days vs. 1 day for explantation). Moreover, no statistically significant difference was found for secondary bleeding (three patients with hemophilia vs. none in the control group; p = 0.11) or surgical complications (five hemophilia patients vs. none with grade I complication; one hemophilia patient vs. none with grade II complications; p = 0.067).
Conclusion
This study has demonstrated that port catheter insertion and removal is safe in these patients. Moreover, it shows the importance of a coordinated approach with a multidisciplinary team.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department for General, Visceral, Thoracic and Vascular Surgery, University Hospital of Bonn, Bonn, Germany.
- Institute of Experimental Haematology and Transfusions Medicine, University Hospital of Bonn, Bonn, Germany.
- Institute for Medical Biometrics, Informatics and Epidemiology, University Hospital of Bonn, Bonn, Germany.
- Department for General and Visceral Surgery, St. Elisabeth-Hospital Leipzig, Leipzig, Germany.
Zitieren
APA
Woestemeier, A., Horneff, S., Lüder, V. M., Nadal, J., Koscielny, A., Kalff, J. C., Oldenburg, J., Goldmann, G., & Lingohr, P. (2026). Perioperative Management for Port Catheter Procedures in Pediatric Patients with Severe Hemophilia and Inhibitors. Hämostaseologie, 46(02), 136-140. https://doi.org/10.1055/a-2337-3687
Vancouver
Woestemeier A, Horneff S, Lüder VM, Nadal J, Koscielny A, Kalff JC, et al. Perioperative Management for Port Catheter Procedures in Pediatric Patients with Severe Hemophilia and Inhibitors. Hämostaseologie. 2026;46(02):136-140. doi:10.1055/a-2337-3687
BibTeX
@article{Woestemeier2026,
author = {Woestemeier, Anna and Horneff, Silvia and Lüder, Vincent Marlon and Nadal, Jennifer and Koscielny, Arne and Kalff, Jörg C and Oldenburg, Johannes and Goldmann, Georg and Lingohr, Philipp},
title = {Perioperative Management for Port Catheter Procedures in Pediatric Patients with Severe Hemophilia and Inhibitors},
journal = {Hämostaseologie},
year = {2026},
volume = {46},
number = {02},
pages = {136--140},
doi = {10.1055/a-2337-3687}
}
EUVIMED